All articles
Does Wegovy® Cause Nausea? Navigating Side Effects and Treatments
Reading time:
5 min
Weight loss

Get expert guidance and a personalized care plan designed around you.
Evaluating Nausea Among Various Weight Loss Medications
When comparing Wegovy® to other weight loss medications like tirzepatide and liraglutide, it's obvious they share similar mechanisms of action, resulting in comparable side effects, including nausea. For Wegovy®, nausea rates range from 16% to 44%, depending on the dosage. Here's a quick breakdown:
Tirzepatide: This newer medication, showing promise in weight management, also impacts appetite and digestion, with nausea reported in approximately 12% to 29% of cases.
Liraglutide: Like Wegovy®, liraglutide affects appetite centers in the brain. Nausea is one of the most commonly reported side effects — nausea rates for liraglutide range from 39% to 42%.
Explore other medications here: https://joinmochi.com/medications
Key Takeaways For Managing Nausea on Wegovy
Nausea is a common side effect of weight loss medications like Wegovy®, often due to its impact on appetite, gastrointestinal motility, and brain pathways.
Approaches to alleviating nausea include eating smaller meals, staying hydrated, and possibly adjusting the medication under a doctor’s guidance.
Wegovy’s effect on nausea is comparable to that of other medications, such as tirzepatide and liraglutide, with the potential for individual variance in response.
Navigating side effects like nausea while using Wegovy® requires a balanced approach of understanding, mitigation strategies, and consulting healthcare providers to find the best way forward for weight loss goals.
If you're seeking personalized weight loss guidance, consider joining Mochi Health. Our team of experts is here to provide you with the support and customized care you need to achieve your health goals. Start your journey to a healthier you with Mochi Health today by filling out this quick eligibility form.
References:
Fulton, S., Horn, C. C., & Zhang, C. (2024). Characterizing a new tool to manipulate area postrema GLP1R+ neurons across species. Physiology & Behavior, 276, 114474–114474. https://doi.org/10.1016/j.physbeh.2024.114474
Kawatani, M., Yamada, Y., & Kawatani, M. (2018). Glucagon-like peptide-1 (GLP-1) action in the mouse area postrema neurons. Peptides (New York, N.Y. : 1980), 107, 68–74. https://doi.org/10.1016/j.peptides.2018.07.010
Hayes, M. R., Borner, T., & De Jonghe, B. C. (2021). The Role of GIP in the Regulation of GLP-1 Satiety and Nausea. Diabetes (New York, N.Y.), 70(9), 1956–1961. https://doi.org/10.2337/DBI21-0004
Veldhuis, P., Melse, M., & Mullaart, N. (2021). Implementation of isopropyl alcohol (IPA) inhalation as the first-line treatment for nausea in the emergency department: practical advantages and influence on the quality of care. International Journal of Emergency Medicine, 14(1), 15–15. https://doi.org/10.1186/s12245-021-00334-z
Cronin, S. N., Odom-Forren, J., Roberts, H., Thomas, M., Williams, S., & Wright, M. I. (2015). Effects of Controlled Breathing, With or Without Aromatherapy, in the Treatment of Postoperative Nausea. Journal of Perianesthesia Nursing, 30(5), 389–397. https://doi.org/10.1016/j.jopan.2015.03.010
Lua, P. L., & Zakaria, N. S. (2012). A Brief Review of Current Scientific Evidence Involving Aromatherapy Use for Nausea and Vomiting. The Journal of Alternative and Complementary Medicine (New York, N.Y.), 18(6), 534–540. https://doi.org/10.1089/acm.2010.0862
Share this post
Weight loss
More articles















